Compile Data Set for Download or QSAR
Report error Found 915 of affinity data for UniProtKB/TrEMBL: O15427
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50349534BDBM50349534(CHEMBL5419465)
Affinity DataIC50: 0.230nMAssay Description:Inhibition of Escherichia coli FabH expressed in Escherichia coli DH10B cells assessed as incorporation of 3H signal in the product after 25 mins by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2024
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50349535BDBM50349535(CHEMBL5399511)
Affinity DataIC50: 0.290nMAssay Description:Inhibition of Escherichia coli FabH expressed in Escherichia coli DH10B cells assessed as incorporation of 3H signal in the product after 25 mins by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2024
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356873BDBM356873(US10214492, Example 223 | US11292767, Example 223)
Affinity DataIC50: 0.300nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356917BDBM356917(US10214492, Example 268 | US11292767, Example 268)
Affinity DataIC50: 0.300nMAssay Description:Inhibition of MCT4 in human MDA-MB-231 cells by BCECF-AM dye based fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356917BDBM356917(US10214492, Example 268 | US11292767, Example 268)
Affinity DataIC50: 0.300nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356917BDBM356917(US10214492, Example 268 | US11292767, Example 268)
Affinity DataIC50: 0.300nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356873BDBM356873(US10214492, Example 223 | US11292767, Example 223)
Affinity DataIC50: 0.300nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356790BDBM356790(US10214492, Example 155 | US11292767, Example 155)
Affinity DataIC50: 0.320nMAssay Description:Inhibition of MCT4 in human MDA-MB-231 cells by BCECF-AM dye based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356790BDBM356790(US10214492, Example 155 | US11292767, Example 155)
Affinity DataIC50: 0.320nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356790BDBM356790(US10214492, Example 155 | US11292767, Example 155)
Affinity DataIC50: 0.320nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 546758BDBM546758((2R)-2-([5-(3,5-Dimethoxyphenyl)-1- [(2-ethoxyphen...)
Affinity DataIC50: 0.350nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356906BDBM356906(US10214492, Example 257 | US11292767, Example 257)
Affinity DataIC50: 0.350nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356906BDBM356906(US10214492, Example 257 | US11292767, Example 257)
Affinity DataIC50: 0.350nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356906BDBM356906(US10214492, Example 257 | US11292767, Example 257)
Affinity DataIC50: 0.350nMAssay Description:Inhibition of MCT4 in human MDA-MB-231 cells by BCECF-AM dye based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356913BDBM356913(US10214492, Example 264)
Affinity DataIC50: 0.350nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356915BDBM356915(US10214492, Example 266 | US11292767, Example 266)
Affinity DataIC50: 0.360nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356915BDBM356915(US10214492, Example 266 | US11292767, Example 266)
Affinity DataIC50: 0.360nMAssay Description:Inhibition of MCT4 in human MDA-MB-231 cells by BCECF-AM dye based fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50637417BDBM50637417(CHEMBL5562438)
Affinity DataIC50: 0.360nMAssay Description:Inhibition of MCT4 in human MDA-MB-231 cells by BCECF-AM dye based assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356915BDBM356915(US10214492, Example 266 | US11292767, Example 266)
Affinity DataIC50: 0.360nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50349533BDBM50349533(CHEMBL5422048)
Affinity DataIC50: 0.380nMAssay Description:Inhibition of Escherichia coli FabH expressed in Escherichia coli DH10B cells assessed as incorporation of 3H signal in the product after 25 mins by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2024
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356870BDBM356870(US10214492, Example 220 | US11292767, Example 220)
Affinity DataIC50: 0.540nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356870BDBM356870(US10214492, Example 220 | US11292767, Example 220)
Affinity DataIC50: 0.540nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356916BDBM356916(US10214492, Example 267 | US11292767, Example 267)
Affinity DataIC50: 0.570nMAssay Description:Inhibition of MCT4 in human MDA-MB-231 cells by BCECF-AM dye based fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356916BDBM356916(US10214492, Example 267 | US11292767, Example 267)
Affinity DataIC50: 0.570nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356916BDBM356916(US10214492, Example 267 | US11292767, Example 267)
Affinity DataIC50: 0.570nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356805BDBM356805(US10214492, Example 167 | US11292767, Example 167)
Affinity DataIC50: 0.590nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356805BDBM356805(US10214492, Example 167 | US11292767, Example 167)
Affinity DataIC50: 0.590nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356805BDBM356805(US10214492, Example 167 | US11292767, Example 167)
Affinity DataIC50: 0.590nMAssay Description:Inhibition of MCT4 in human MDA-MB-231 cells by BCECF-AM dye based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356811BDBM356811(US10214492, Example 172 | US11292767, Example 172)
Affinity DataIC50: 0.590nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356811BDBM356811(US10214492, Example 172 | US11292767, Example 172)
Affinity DataIC50: 0.590nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356909BDBM356909(US10214492, Example 260 | US11292767, Example 260)
Affinity DataIC50: 0.830nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356909BDBM356909(US10214492, Example 260 | US11292767, Example 260)
Affinity DataIC50: 0.830nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50349536BDBM50349536(CHEMBL5425432)
Affinity DataIC50: 0.910nMAssay Description:Inhibition of Escherichia coli FabH expressed in Escherichia coli DH10B cells assessed as incorporation of 3H signal in the product after 25 mins by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2024
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 345281BDBM345281(2-[[1-[(2-Chlorophenyl)methyl]-5-(3- isobutoxyphe...)
Affinity DataIC50: 1nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50606664BDBM50606664(CHEMBL1616099)
Affinity DataIC50: 1nMAssay Description:Inhibition of MCT4 in human NCI-H358 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 345281BDBM345281(2-[[1-[(2-Chlorophenyl)methyl]-5-(3- isobutoxyphe...)
Affinity DataIC50: 1nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2023
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50606663BDBM50606663(CHEMBL5219543)
Affinity DataIC50: 1nMAssay Description:Inhibition of MCT4 in human NCI-H358 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50606663BDBM50606663(CHEMBL5219543)
Affinity DataIC50: 1nMAssay Description:Inhibition of MCT4 in human MDA-MB-231 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 345281BDBM345281(2-[[1-[(2-Chlorophenyl)methyl]-5-(3- isobutoxyphe...)
Affinity DataIC50: 1nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356918BDBM356918(US10214492, Example 269 | US11292767, Example 269)
Affinity DataIC50: 1nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50606665BDBM50606665(SYROSINGOPINE | Syrosingopine | Isotense | Londomi...)
Affinity DataIC50: 1nMAssay Description:Inhibition of MCT4 in human NCI-H358 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 345281BDBM345281(2-[[1-[(2-Chlorophenyl)methyl]-5-(3- isobutoxyphe...)
Affinity DataIC50: 1nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356918BDBM356918(US10214492, Example 269 | US11292767, Example 269)
Affinity DataIC50: 1nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50606665BDBM50606665(SYROSINGOPINE | Syrosingopine | Isotense | Londomi...)
Affinity DataIC50: 1nMAssay Description:Inhibition of MCT4 in human MDA-MB-231 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50606664BDBM50606664(CHEMBL1616099)
Affinity DataIC50: 1nMAssay Description:Inhibition of MCT4 in human MDA-MB-231 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 345298BDBM345298(2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclopentyl...)
Affinity DataIC50: 1.10nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 345298BDBM345298(2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclopentyl...)
Affinity DataIC50: 1.10nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 345298BDBM345298(2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclopentyl...)
Affinity DataIC50: 1.10nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 345298BDBM345298(2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclopentyl...)
Affinity DataIC50: 1.10nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2023
Entry Details
US Patent

TargetMonocarboxylate transporter 4(Human)
Astrazeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 356764BDBM356764(US10214492, Example 128 | US11292767, Example 128)
Affinity DataIC50: 1.20nMAssay Description:MDA-MB-231 breast cancer cells may be used to measure MCT4 activity in cells with high native levels of MCT4 and low levels of MCT1 and are known to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

Displayed 1 to 50 (of 915 total ) | Next | Last >>
Jump to: